This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilbaux, M.
Right arrow Articles by Van Melderen, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilbaux, M.
Right arrow Articles by Van Melderen, L.

 Previous Article  |  Next Article 

Journal of Bacteriology, April 2007, p. 2712-2719, Vol. 189, No. 7
0021-9193/07/$08.00+0     doi:10.1128/JB.01679-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Functional Interactions between Coexisting Toxin-Antitoxin Systems of the ccd Family in Escherichia coli O157:H7{triangledown}

Myriam Wilbaux,1 Natacha Mine,1 Anne-Marie Guérout,2 Didier Mazel,2 and Laurence Van Melderen1*

Laboratoire de Génétique des Procaryotes, Institut de Biologie et Médecine Moléculaires, Université Libre de Bruxelles, 12 Rue des Professeurs Jeener et Brachet, 6041 Gosselies, Belgium,1 Unité Plasticité du Génome Bactérien, Département Génomes et Génétique, Institut Pasteur, 25 Rue du Dr. Roux, 75724 Paris, France2

Received 30 October 2006/ Accepted 16 January 2007


arrow
ABSTRACT
 
Toxin-antitoxin (TA) systems are widely represented on mobile genetic elements as well as in bacterial chromosomes. TA systems encode a toxin and an antitoxin neutralizing it. We have characterized a homolog of the ccd TA system of the F plasmid (ccdF) located in the chromosomal backbone of the pathogenic O157:H7 Escherichia coli strain (ccdO157). The ccdF and the ccdO157 systems coexist in O157:H7 isolates, as these pathogenic strains contain an F-related virulence plasmid carrying the ccdF system. We have shown that the chromosomal ccdO157 system encodes functional toxin and antitoxin proteins that share properties with their plasmidic homologs: the CcdBO157 toxin targets the DNA gyrase, and the CcdAO157 antitoxin is degraded by the Lon protease. The ccdO157 chromosomal system is expressed in its natural context, although promoter activity analyses revealed that its expression is weaker than that of ccdF. ccdO157 is unable to mediate postsegregational killing when cloned in an unstable plasmid, supporting the idea that chromosomal TA systems play a role(s) other than stabilization in bacterial physiology. Our cross-interaction experiments revealed that the chromosomal toxin is neutralized by the plasmidic antitoxin while the plasmidic toxin is not neutralized by the chromosomal antitoxin, whether expressed ectopically or from its natural context. Moreover, the ccdF system is able to mediate postsegregational killing in an E. coli strain harboring the ccdO157 system in its chromosome. This shows that the plasmidic ccdF system is functional in the presence of its chromosomal counterpart.


arrow
INTRODUCTION
 
Toxin-antitoxin (TA) proteic systems were originally discovered on low-copy-number plasmids (for reviews on TA systems, see references 11, 22, 24, and 29). They are composed of two genes organized in an operon encoding a toxin and an antitoxin that antagonizes it. The expression of the TA genes is autoregulated at the transcriptional level; the antitoxin acts as a repressor and the toxin often as a corepressor. The antitoxin is an unstable protein degraded by an ATP-dependent protease, while the toxin is a stable protein that inhibits an essential cellular process (e.g., replication and translation). TA systems contribute to plasmid stability by a mechanism called postsegregational killing (PSK). PSK relies on the differential stabilities of the antitoxin and toxin proteins and leads to the killing of daughter bacteria that did not receive a plasmid copy at cell division (31, 50, 53).

Recent computational analyses have shown that TA systems are widely represented in eubacterial and archaebacterial chromosomes, suggesting a role for horizontal gene transfer in the spread of these genes (5, 6, 38). The localization of chromosomal TA systems is quite varied. Some are localized within exogenous DNA islands like phages (relBEK-12 in the cryptic lambdoid Qin prophage of Escherichia coli MG1655) (40), transposons (relBE homolog in Tn5401 of Bacillus thuringiensis (23), and superintegrons (relBE, parDE, phd-doc, and higAB homologs in the superintegron of Vibrio cholerae [17, 38, 41]). Others, such as mazEF (chpA) and chpB of E. coli K-12, are apparently settled in the chromosome, flanked by metabolic or regulatory genes (35, 36). The chromosomal TA systems were shown to be activated under stress conditions, although the outcomes of activation appear to be different for the various systems. On the one hand, the mazEF system was shown to be a suicide module leading to cell death under various stressful conditions (e.g., overproduction of ppGpp, DNA damage, high temperatures, and oxidative stress) (2, 4, 30, 46, 47). On the other hand, the mazEF and relBEK-12 systems have been described as growth modulators under conditions of amino acid starvation (15, 16, 39). The function of TA systems localized in transposons or superintegrons could be similar to that of plasmidic TA systems, i.e., they could stabilize these exogenous DNA islands within the bacterial genome (17, 41).

We have performed a functional analysis of the chromosomal ccdO157 system of E. coli O157:H7, which is homologous to the ccd TA system of the F plasmid (ccdF) (for reviews on ccd, see references 19 and 52). The ccdF system is composed of the unstable CcdAF antitoxin, which is degraded by the Lon ATP-dependent protease (53, 54), and of the stable CcdBF toxin. Both CcdAF and CcdBF are required for autoregulation (1, 42, 49). CcdBF targets the DNA gyrase and leads to replication and transcription inhibition, SOS induction, and ultimately, to cell death (8, 9, 20, 31, 34). The ccdF and the ccdO157 systems coexist in E. coli O157:H7 isolates; the ccdF system is present on an F-related virulence plasmid (pO157), while the ccdO157 system is present on the chromosome. Therefore, we have tested whether the components of these systems interact and showed that the ccdF system is functional in the presence of its chromosomal homolog.


arrow
MATERIALS AND METHODS
 
Bacterial strains, plasmids, and media. Strains and plasmids used in this work are listed in Table 1.


View this table:
[in this window]
[in a new window]

  		TABLE 1. Bacterial strains and plasmids used in this study

Construction of the O55:H7{Delta}ccdO157 strain. The pKOBEG plasmid (12) was used as described at the website http://www.pasteur.fr/recherche/unites/Ggb/3SPCRprotocol.html. The kanamycin resistance cassette of pKD4 was amplified by PCR with the following primers: P1 (5' ATA CTA GAC GTA TAA ATT GTA CAG GAG CAC GAT ATC GTG TAG GCT GGA GCT GCT TC) and P2 (5' AAG GAT TTG GGT GAG GGA GAG GCG GTC GCG TCT TAA CAT ATG AAT ATC CTC CTT AG). Deletion of the ccdO157 system was constructed by following the method described in reference 21. The deletion and the flanking regions were checked by DNA sequencing.

Construction of plasmids. (i) Expression plasmids. The expression plasmids are isogenic, i.e., all the open reading frames (ORFs) were cloned using the same restriction sites in the expression vectors, and all the regulatory sequences were added by PCR (the Shine-Dalgarno box and the sequence between the Shine-Dalgarno box and the ATG of the ORFs were identical).

To construct the pBAD-ccdBF plasmid, the ccdB gene from the F plasmid was amplified by PCR using pULB2250 as a template (8) and the following primers: 5'CcdB-XbaI (5'TCT AGA AGG AGG GTG AAA TGC AGT TTA AGG) and 3'CcdB-PstI (5'AGT CTC TGC AGT TAT ATT CCC CAG AAC). The PCR product was cloned into the TOPO-XL vector (Invitrogen). The resulting plasmid was then digested by XbaI and PstI. The fragment containing ccdBF was inserted into pBAD33 that was opened by the same enzymes. The ligation mixture was transformed in strain B462.

To construct the pBAD-ccdBO157 plasmid, the ccdB gene from E. coli O157:H7 was amplified by PCR using E. coli O157:H7 chromosomal DNA (ATCC 700927) as a template and the following primers: 5'CcdBO157-XbaI (5'TCT AGA AGG AGG TAG CGA TGC AAT TTA CGG) and 3'CcdBO157-PstI (5'AGT CTC TGC AGT TAA ATC CCG TCG AGC). The PCR product was digested by XbaI and PstI and inserted into pBAD33 that was digested with the same enzymes. The ligation mixture was transformed in strain B462.

To construct the pKK-ccdAO157 plasmid, the ccdA gene from E. coli O157:H7 was amplified by PCR using E. coli O157:H7 chromosomal DNA (ATCC 700927) as a template and the following primers: 5'CcdAO157-EcoRI (5'TTG TGA ATT CTA TGA CTG CAA AAC GTA CCA) and 3'CcdAO157-PstI (5'AGT CTC TGC AGC TAG AAG CTC CGG TAC TC). The PCR product was cloned into the TOPO-XL vector (Invitrogen). The resulting plasmid was then digested by EcoRI and PstI. The fragment containing ccdAO157 was inserted into pKK223-3 that was opened by the same enzymes.

(ii) Promoter activity plasmids. To construct the pJL-OPccdO157 plasmid, the operator/promoter region of the ccdO157 operon was amplified by PCR using the Topo-folAccdO157 plasmid (see below) as a template and the following primers: 5'O/P2-ccdO157 (5'GGT ATT CAG CGA ATT CCA CGA CGC TG) and 3'O/P2-ccdO157 (5'TCA GCA TTG AGC GCA ACC GTA AGG G). The PCR product was cloned into the TOPO-XL vector (Invitrogen). The resulting plasmid was then digested by HindIII and PstI (sites from the TOPO-XL vector). The fragment containing the operator/promoter region of the ccdO157 operon was inserted into pJL207 that was opened by the same enzymes.

The Topo-folAccdO157 plasmid was constructed by amplifying the chromosomal region comprising the folA gene and the ccdO157 operon by PCR using E. coli O157:H7 chromosomal DNA (ATCC 700927) as a template and the following primers: 5'folA (5'CCC TCA TCC TAA TAA AGA GTG ACG) and 3'operon-ccdO157 (5'CGA ACC GGC ATA AGG ATT TGG GTG AGG G). The PCR product was cloned into the TOPO-XL vector (Invitrogen).

To construct the pKT-ccdO157 plasmid, the ccdO157 operon was amplified by PCR using E. coli O157:H7 chromosomal DNA (ATCC 700927) as a template and the following primers: 5'operon-ccdO157 (5'GAG ATT CTG GAG CGG CGG TAA TTT TG) and 3'operon-ccdO157 (5'CGA ACC GGC ATA AGG ATT TGG GTG AGG G). The PCR product was cloned into the TOPO-XL vector (Invitrogen). The resulting plasmid was digested by EcoRI and then inserted into the pKT279 plasmid digested by EcoRI.

(iii) Postsegregational killing plasmids. To construct the pMLO-ccdO157 plasmid, the ccdO157 operon was amplified by PCR using E. coli O157:H7 chromosomal DNA (ATCC 700927) as a template and the following primers: 5'operon-ccdO157 (5'GAG ATT CTG GAG CGG CGG TAA TTT TG) and 3'operon-ccdO157 (5'CGA ACC GGC ATA AGG ATT TGG GTG AGG G). The PCR product was cloned into the TOPO-XL vector (Invitrogen). The resulting plasmid was then digested by HindIII and XbaI. The fragment containing the ccdO157 operon was blunted using the Klenow enzyme and then inserted into the pMLO59 plasmid digested by SmaI.

All the plasmids and the intermediate constructs that were constructed were sequenced.

Media. Luria-Bertani medium (LB) (37), Ceria 132 synthetic medium (CM) (25), and CM supplemented with 0.1% Casamino Acids (CCM) were used.

DNA manipulations. Transformations with appropriate plasmids were performed as described in reference 37, and most routine DNA manipulations were performed as described in reference 43.

Toxicity and antitoxicity assays. Strains carrying the toxin-expressing plasmids and/or the antitoxin-expressing plasmids were grown overnight (ON) at 37°C in CCM supplemented with glucose (0.4%) and the appropriate antibiotics. ON cultures were diluted in the same medium to an optical density (OD) at 600 nm of ~0.01 and grown at 37°C to an OD600 of ~0.1 to 0.2. The cultures were centrifuged at 4,000 rpm for 10 min at room temperature. The bacterial pellets were resuspended in CCM, prewarmed at 37°C, and supplemented with glycerol (0.4%) and the appropriate antibiotics. Arabinose was then added (0.25% or 1%), and the cultures were grown at 37°C. No IPTG (isopropyl-ß-D-thiogalactopyranoside) was added. Samples were removed at 0, 10, 20, and 30 min, diluted in MgSO4 (10 mM), and plated on CCM plates supplemented with glucose (0.4%) and the appropriate antibiotics. Plates were incubated ON at 37°C.

Postsegregational killing assay. O55:H7 and O55:H7{Delta}ccdO157 containing the pMLO59 vector and its derivatives were grown ON at 30°C in LB containing spectinomycin (100 µg/ml). ON cultures were centrifuged at 4,000 rpm for 10 min at room temperature and resuspended in LB. Cultures were then diluted 400-fold in LB and grown at 30°C and at 42°C. Cultures were diluted every 45 min to maintain an OD600 of ~0.1 to 0.2. Samples were removed at 0, 45, 90, 135, 180, 225, 270, and 315 min, diluted in MgSO4 (10 mM), and plated on LB plates and on LB plates supplemented with spectinomycin. Plates were incubated ON at 30°C.

Promoter activity assay. CSH50/pJL-OPccdF and CSH50/pJL-OPccdO157 containing the pKT279 vector or its derivatives were grown at 37°C in LB containing chloramphenicol (20 µg/ml) and tetracycline (15 µg/ml) to an OD600 of ~0.3. Samples were removed, and ß-galactosidase assays were performed as described in reference 57.

Protein sample preparation, sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis, and Western blot analysis. We transferred 1-ml samples from cultures to tubes containing 50 µl of cold 100% trichloroacetic acid. After centrifugation, pellets were washed twice with 500 µl of cold 100% acetone, air dried, and resuspended in SDS-gel loading buffer. Equal amounts of protein were separated on a 15% SDS-polyacrylamide gel electrophoresis gel and transferred to nitrocellulose filters. Filters were incubated with polyclonal anti-CcdAF antibodies. Immunoblots were developed by using horseradish peroxidase-conjugated goat anti-rabbit and enhanced chemiluminescence (Amersham).

Because of the low sensitivity of the anti-CcdAF antibodies against the CcdAO157 protein, concentrations of protein extracts from strains producing CcdAO157 were fivefold higher than those from strains producing CcdAF to reach comparable detection levels.


arrow
RESULTS
 
Diversity of the folA-apaH region in E. coli strains. Using TBLASTN, several ORFs coding for proteins nearly identical to the CcdAF and CcdBF proteins encoded by the F plasmid (83 to 100% identity) were found in virulence F-related plasmids (e.g., pO157 of E. coli O157:H7, pINV of Shigella flexneri, and pSLT of Salmonella enterica serovar Typhimurium). Interestingly, we found that ORFs coding for proteins with less identity (30% and 35% with CcdAF and CcdBF, respectively) (Fig. 1) were present at the same chromosomal location in 5 of the 17 E. coli strains partially or totally sequenced (O157:H7 EDL933, O157:H7 VT-Sakai, O6:H1 CFT073, O6:H31 536, and O6:H31 F11). Note that all these strains are pathogenic. The ccdF homolog is located in a 637-bp region, between the folA and the apaH genes, outside of any identifiable mobile genetic element. folA and apaH are metabolic genes encoding a dihydrofolate reductase and a diadenosine tetraphosphatase, respectively. This chromosomal homolog was named ccdO157. The ccdO157 system is also present between folA and apaH in the UTI89 strain, although a frameshift (+1) mutation occurred in the ORF corresponding to CcdBO157, leading most likely to an inactive protein. A 77-bp intergenic region between folA and apaH was detected in nine E. coli strains (K-12 MG1655, K-12 W3110, O103:H2 E22, O111:NM B171, O144 53638, O9 HS, O139:H28 E24377A, 101-1, and H10407). In two E. coli strains (O148:H28 B7 and O111:H9 E110019), a region of 1,434 bp was detected at the same location. We identified in this region a sequence without a start codon coding for 29 amino acids homologous to the C-terminal part of CcdAO157. We did not find any sequence corresponding to CcdBO157.


Figure 1
View larger version (11K):
[in this window]
[in a new window]

  		FIG. 1. Homology between the CcdA and CcdB proteins. Proteic sequences of the CcdA and CcdB proteins from the F plasmid and E. coli O157:H7 were aligned with the CLUSTALW program. Symbols: asterisk, identical amino acids; colon, strongly similar amino acids; period, weakly similar amino acids. The total number of amino acids for each protein is in parentheses. The G100 and I101 active sites are indicated in bold.

We studied the ccdO157 system of E. coli O157:H7, since O157:H7 isolates contain an F-related virulence plasmid (pO157) that carries the ccdF system. Therefore, in these natural isolates, both ccd systems have been maintained throughout the evolution.

The E. coli O157:H7 chromosomal ccd system (ccdO157) encodes a toxin-antitoxin gene pair. We tested the activity of CcdAO157 and CcdBO157 to determine whether the ccdO157 system encodes a toxin-antitoxin gene pair. ccdBF and ccdBO157 were cloned in the pBAD33 vector under the control of the arabinose-inducible promoter pBAD, while ccdAF and ccdAO157 were cloned in the compatible pKK223-3 vector under the control of the IPTG-inducible promoter pTac. E. coli K-12 strains containing the various constructs were grown exponentially, and ccdBF and ccdBO157 transcription was induced at time zero by the addition of arabinose (Fig. 2). As observed for CcdBF, the production of CcdBO157 results in a dramatic decrease in viable counts (by about 2 logs) after 10 min of induction. Viability is not affected in the presence of the cognate antitoxins (CcdAF and CcdAO157). This shows that the chromosomal ccdO157 system encodes functional toxin and antitoxin proteins.


Figure 2
View larger version (14K):
[in this window]
[in a new window]

  		FIG. 2. The ccdO157 system carries a toxin-antitoxin gene pair. SG22622/pKK223-3/pBAD-ccdBF (filled squares), SG22622/pKK223-3/pBAD-ccdBO157 (filled triangles), SG22622/pKK-ccdAF/pBAD-ccdBF (open squares), and SG22622/pKK-ccdAO157/pBAD-ccdBO157 (open triangles) were grown as described in Materials and Methods. After the addition of 1% arabinose, serial dilutions of the cultures were plated without arabinose and incubated overnight at 37°C. Values correspond to the means of results of three independent experiments.

CcdBF kills plasmid-free segregant bacteria by poisoning the DNA gyrase, an essential topoisomerase II (8, 9). To determine whether the CcdBO157 toxin also targets the DNA gyrase, the pBAD-ccdBO157 plasmid was transformed in a wild-type strain and in the isogenic strain carrying the CcdBF-resistant mutation gyrA462. Table 2 shows that the transformation efficiency for the pBAD-ccdBF and pBAD-ccdBO157 plasmids in the wild-type strain is very low in the presence of 1% arabinose (<10–4), while it is comparable to that of the vector in the CcdBF-resistant strain. This shows that the DNA gyrase is the cellular target of CcdBO157. The key amino acids of the toxic active site of CcdBF have been previously identified as glycine100 and isoleucine101 (7). These two carboxy-terminal amino acids are conserved in CcdBO157 (Fig. 1). We introduced the G100R or I101K mutations in CcdBO157 and found that these mutations completely abolished the toxic activity of CcdBO157 (data not shown), indicating that the active site of CcdBF is conserved in CcdBO157.


View this table:
[in this window]
[in a new window]

  		TABLE 2. Like CcdBF, the CcdBO157 toxin targets the DNA gyrase

CcdAF is unstable and degraded by the Lon ATP-dependent protease. Figure 3 shows that the half-life of CcdAO157 in a wild-type strain is comparable to that of CcdAF (~30 min) and that both antitoxins are stabilized in a {Delta}lon strain. Thus, CcdAO157 is a Lon substrate.


Figure 3
View larger version (58K):
[in this window]
[in a new window]

  		FIG. 3. Turnover of the CcdAF and CcdAO157 antitoxins. SG226222 (wild type [wt]) and SG22623 ({Delta}lon mutant) carrying either the pKK-ccdAF or the pKK-ccdAO157 plasmid were grown to early log phase in LB at 37°C. Spectinomycin was added (100 µg/ml) to block protein synthesis. Culture samples were removed at the times indicated in the figure. Protein extraction and Western blot analysis were performed as described in Materials and Methods.

The putative promoter region of the ccdO157 system was cloned in a plasmid carrying a promoter-free lacZ gene (pJL-OPccdO157). Table 3 shows that the promoter activity of the ccdO157 system is fivefold weaker than that of the ccdF system. Regions of various lengths upstream and encompassing the 5' end of the ccdAO157 gene were tested, and their transcriptional activities are comparable to that of pJL-OPccdO157 (data not shown). We analyzed the autoregulation property of the ccdO157 system and found that its expression is autoregulated by CcdAO157 and CcdBO157 proteins expressed in trans (Table 3). However, the autoregulation appears to be less efficient than that of the ccdF system (60% versus 90% of repression).


View this table:
[in this window]
[in a new window]

  		TABLE 3. Promoter activity and autoregulation of the ccdF and ccdO157 systems

Interactions between the ccdF and the ccdO157 systems. As the ccdO157 and the ccdF systems coexist in E. coli O157:H7 isolates, we tested the cross-interactions between the components of the two systems. The ability of each antitoxin to counteract the toxic activity of its noncognate toxin was assayed in E. coli K-12. The expression of CcdBF and CcdBO157 from the pBAD promoter results in a dramatic loss of viable counts. Basal expression of CcdAF from the pTac promoter in trans restores the viability of bacteria producing either CcdBO157 or CcdBF (Fig. 4A). CcdAF is thus as able to efficiently counteract the toxic activity of CcdBO157 as its cognate toxin. However, expression of CcdAO157 from the pTac promoter is unable to counteract CcdBF toxicity (Fig. 4B), even under overproduction conditions (in the presence of 1 mM IPTG) (data not shown).


Figure 4
View larger version (13K):
[in this window]
[in a new window]

  		FIG. 4. Interactions between the ccdF and the ccdO157 systems. All strains were grown as described in Materials and Methods and treated as described in the legend for Fig. 2. Values correspond to the means of results of three independent experiments. Data shown were obtained from the same experiments and are represented in two panels for clarity. (A) Ability of CcdAF to counteract the toxic activity of CcdBO157 SG22622/pKK223-3/pBAD-ccdBF (filled squares), SG22622/pKK223-3/pBAD-ccdBO157 (filled triangles), SG22622/pKK-ccdAF/pBAD-ccdBF (open squares), and SG22622/pKK-ccdAF/pBAD-ccdBO157 (open triangles). (B) Ability of CcdAO157 to counteract the toxic activity of CcdBF SG22622/pKK223-3/pBAD-ccdBF (filled squares), SG22622/pKK223-3/pBAD-ccdBO157 (filled triangles), SG22622/pKK-ccdAO157/pBAD-ccdBF (open squares), and SG22622/pKK-ccdAO157/pBAD-ccdBO157 (open triangles).

We also tested the cross-interactions between the ccdF and the ccdO157 systems in an E. coli strain carrying the ccdO157 system in its chromosome. For that purpose, we could not use the O157:H7 strain, since it contains the pO157 plasmid carrying the ccdF system.

Evolutionary analyses have shown that O55:H7 strains are genetically closely related to O157:H7 strains (55, 56), although they are devoid of the pO157 plasmid. We screened O55:H7 isolates by PCR using two sets of primers, one specific to ccdO157 and the other to ccdF, and confirmed that these strains carry ccdO157 but lack ccdF. DNA sequencing revealed that the ccdO157 system and its flanking regions are identical to those of O157:H7 (data not shown). A deletion of the ccdO157 system was constructed in O55:H7 (O55:H7{Delta}ccdO157; see Materials and Methods).

Strains O55:H7 and O55:H7{Delta}ccdO157 were transformed with the pBAD-ccdBF and the pBAD-ccdBO157 plasmids. The viabilities of both strains were measured upon expression of the CcdBF and CcdBO157 toxins. Figure 5 shows that the viability of O55:H7 is only slightly affected after 30 min of CcdBO157 induction, while it is largely reduced by that of CcdBF (by about 2 logs). This shows that CcdAO157 is produced from its natural location at a basal level that is sufficient to at least partially counteract the toxic activity of CcdBO157 produced in trans. These results also confirm that CcdAO157 is unable to counteract CcdBF produced in trans. On the other hand, the viability of O55:H7{Delta}ccdO157 is drastically affected by the expression of both toxins (Fig. 5).


Figure 5
View larger version (14K):
[in this window]
[in a new window]

  		FIG. 5. Expression of the chromosomal ccdO157 system in the O55:H7 E. coli strain. O55:H7 (squares) and O55:H7{Delta}ccdO157 (triangles) containing pBAD-ccdBF (filled symbols) or pBAD-ccdBO157 (open symbols) plasmids were grown as described in Materials and Methods. After addition of 0.25% arabinose, serial dilutions of the cultures were plated without arabinose and incubated ON at 37°C. Values correspond to the means of results for three independent experiments.

The ccdF system is able to mediate postsegregational killing in the presence of its chromosomal homolog ccdO157. The chromosomal CcdAO157 antitoxin, whether expressed ectopically or in its natural context, is not able to counteract the plasmidic CcdBF toxin. Therefore, we tested whether the ccdF system is able to mediate PSK in the presence of ccdO157. The O55:H7 strain that carries the ccdO157 system in its chromosome was transformed with a conditionally replicating (thermosensitive) plasmid carrying the ccdF system (pMLO59-ccdF). Figure 6 shows that, after 180 min of culture at 42°C, the ability of O55:H7/pMLO59-ccdF to form colonies decreases in comparison with that of the control strain O55:H7/pMLO59. It only slightly increases during the next 135 min of the experiment, showing that the loss of pMLO59-ccdF mediates PSK. Thus, the ccdF system is functional for plasmid stabilization in an E. coli strain carrying the ccdO157 system in its chromosome.


Figure 6
View larger version (11K):
[in this window]
[in a new window]

  		FIG. 6. The ccdF system mediates postsegregational killing in the O55:H7 E. coli strain. O55:H7 containing the pMLO59 vector (diamond) and its derivative carrying the ccdF system (squares) were grown as described in Materials and Methods. Exponential cultures in LB at 42°C were sampled at the times indicated in the figure. Surviving bacteria were scored as the number of CFU on LB plates at 30°C. Values correspond to the means of results for three independent experiments.

The ccdO157 system is unable to mediate postsegregational killing. TA systems located in mobile genetic elements such as plasmids (e.g., ccdF and relBEp307), prophages (relBEK-12), and superintegrons (higBA) have been shown to be able to mediate PSK (17, 26, 27, 31). We tested the capacity of the chromosomal ccdO157 system to mediate PSK using the same system described above. The O55:H7{Delta}ccdO157 strain was transformed with the pMLO59-ccdF or the pMLO59-ccdO157 plasmid. As expected, the loss of pMLO59-ccdF decreases the ability of the O55:H7{Delta}ccdO157 strain to form colonies after 180 min of culture at 42°C. On the contrary, the loss of pMLO59-ccdO157 does not affect the ability of the O55:H7{Delta}ccdO157 strain to form colonies, even after 315 min of culture at 42°C (Fig. 7). As a control, we confirmed that the loss of both plasmids is comparable to that of the pMLO59 vector control (data not shown).


Figure 7
View larger version (12K):
[in this window]
[in a new window]

  		FIG. 7. The ccdO157 system is unable to mediate postsegregational killing. O55:H7{Delta}ccdO157 containing the pMLO59 vector (squares) and its derivatives carrying either the ccdF (triangles) or the ccdO157 (diamonds) system were grown as described in Materials and Methods. Exponential cultures in LB at 42°C were sampled at the times indicated in the figure. Surviving bacteria were scored as the number of CFU on LB plates at 30°C. The values correspond to the means of results for three independent experiments.


arrow
DISCUSSION
 
TA systems are abundant in bacterial chromosomes and on mobile genetic elements such as plasmids, phages, and transposons (24). Computational analyses have grouped TA systems in families based on proteic sequence similarities and sequence profile analysis (5, 38). Members of a given family often coexist in the same bacteria. For instance, the relBE and the vapBC families are represented at 9 and 13 copies, respectively, in the chromosome of Nitrosomonas europaea (38). Situations in which plasmidic and chromosomal systems belonging to the same family are present in the same bacteria also exist. We have identified such a situation in the pathogenic E. coli O157:H7 strains, since they contain the plasmidic ccdF system located on an F-derivative virulence plasmid (pO157) and a chromosomal homolog of this plasmidic system, the ccdO157 system.

The ccdO157 chromosomal system is located between the folA and apaH genes in the chromosomes of 5 of the 17 sequenced E. coli strains. This heterogeneous distribution among the E. coli species suggests that the ccdO157 system has been acquired by horizontal gene transfer. In the nine E. coli strains lacking it, a palindromic unit sequence is found in the folA-apaH intergenic region. Since palindromic units are specific targets for IS1397 insertion (18), an attractive hypothesis is that a composite transposon carrying an ancestral ccd system and other genes may have hopped in this specific site. DNA rearrangements as well as coevolution with the host genome may have occurred (e.g., GC content of ccdO157 [49%] is close to that of the chromosome of O157:H7 [50%]), leading to the actual ccdO157 system. The folA-apaH intergenic region seems to be subject to insertion events, as a DNA segment containing an ORF coding for a hypothetical protein of unknown function and a sequence homologous to the C-terminal part of CcdAO157 has been detected in 2 of the 17 E. coli strains (data not shown).

The chromosomal relBEK-12 and mazEF systems of E. coli K-12 have been described as having a function in bacterial physiology (2, 14, 15, 16, 30, 47). However, each system seems to have a different function and/or a different function under different physiological conditions. mazEF is activated by numerous stresses and leads to cell death (22, 30), while activation of relBEK-12 appears to be more specific to amino acid starvation and results in growth inhibition (15, 39). Although we do not yet have data involving the ccdO157 system in the E. coli physiology, we have shown that it is expressed in its natural context, i.e., in O55:H7 E. coli isolates. We have shown that, unlike the ccdF system, the ccdO157 system is unable to mediate postsegregational killing. The weak promoter activity of ccdO157 in comparison with that of ccdF, rather than the toxicity of CcdBO157, is likely to be responsible for its inability to mediate PSK, since CcdBO157, when expressed ectopically, causes a reduction in viability comparable to that of CcdBF. A low transcriptional activity might reflect the adaptation of the ccdO157 system to its chromosomal location. It is likely that chromosomal TA systems might have to adapt to their hosts to be maintained throughout evolution. Therefore, their regulation might be more complex and integrated than that of plasmidic TA systems. For instance, the alarmone ppGpp regulates negatively the transcription of the mazEF system in E. coli K-12 (2).

The ccdF and ccdO157 systems naturally coexist in O157:H7 isolates, as these strains contain an F-derivative virulence plasmid (pO157), which is ccdF+. Our cross-talk experiments have shown that the chromosomal CcdAO157 antitoxin is not able to counteract the plasmidic CcdBF toxin, even under overproduction conditions, while the plasmidic CcdAF antitoxin is able to counteract the chromosomal CcdBO157 toxin. Moreover, we have shown that the ccdF system is able to mediate PSK in an E. coli O55:H7 strain harboring the ccdO157 system in its chromosome, showing that the ccdF system is functional in the presence of its chromosomal counterpart. A similar observation was made for the pem (parD) TA system located on the R100 (R1) plasmid of E. coli. The two antitoxins of its chromosomal homologs (mazEF and chpB) are unable to counteract the toxicity of the plasmid-encoded toxin (PemK) (35), explaining how the pem system is able to stabilize plasmids in E. coli (51). However, mutants of the antitoxins of the mazEF and chpB systems are able to counteract PemK toxicity (44, 45), most likely due to an overproduction of the chromosomal antitoxins. In our experiments, overproduction of the chromosomal CcdAO157 antitoxin does not counteract the plasmidic CcdBF toxin (data not shown). Thus, only plasmidic TA systems able to evade cross-interaction seem to coexist with their chromosomal homologs. This raises the hypothesis that chromosomal TA systems might serve as "exclusion" systems to protect bacteria from being loaded with an excess of exogenous DNA carrying identical TA systems (plasmids, transposons, phages) (18a, 41). a function somewhat reminiscent of that of restriction-modification (RM) systems (for a review on RM, see reference 32). RM and TA systems share several properties. They are located in plasmids as well as in chromosomes, they seem to move from one location to another through horizontal gene transfer, and they are able to mediate PSK when cloned on an unstable plasmid. Further experiments are needed to test whether certain TA systems might promote the "exclusion" of incoming homologous TA systems.


arrow
ACKNOWLEDGMENTS
 
We are grateful to Susan Gottesman for helpful suggestions and critical reading of the manuscript. We thank Christophe Beloin and Jean-Marc Ghigo for providing us with the pKOBEG plasmid. We also thank Beth Whittam from the STEC Center (Michigan State University) for kindly providing us with the O55:H7 strain.

This work was supported by the FNRS (FRSM 3.4510.02), the Institut Pasteur, the CNRS (URA 2171), MENESR, and the European Union (STREP LSH-2004-2.1.2-2). L.V.M. is Chercheur Qualifié at the FNRS. M.W. is supported by the FRIA.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Laboratoire de Génétique des Procaryotes, Institut de Biologie et Médecine Moléculaires, Université Libre de Bruxelles, 12 Rue des Professeurs Jeener et Brachet, 6041 Gosselies, Belgium. Phone: 32 2 650 97 78. Fax: 32 2 650 97 70. E-mail: lvmelder{at}ulb.ac.be. Back

{triangledown} Published ahead of print on 26 January 2007. Back


arrow
REFERENCES
 
    1
  1. Afif, H., N. Allali, M. Couturier, and L. Van Melderen. 2001. The ratio between CcdA and CcdB modulates the transcriptional repression of the ccd poison-antidote system. Mol. Microbiol. 41:73-82.[CrossRef][Medline]
    2. 2
  2. Aizenman, E., H. Engelberg-Kulka, and G. Glaser. 1996. An Escherichia coli chromosomal "addiction module" regulated by guanosine [corrected] 3',5'-bispyrophosphate: a model for programmed bacterial cell death. Proc. Natl. Acad. Sci. USA 93:6059-6063.[Abstract/Free Full Text]
    3. 3
  3. Allali, N., H. Afif, M. Couturier, and L. Van Melderen. 2002. The highly conserved TldD and TldE proteins of Escherichia coli are involved in microcin B17 processing and in CcdA degradation. J. Bacteriol. 184:3224-3231.[Abstract/Free Full Text]
    4. 4
  4. Amitai, S., Y. Yassin, and H. Engelberg-Kulka. 2004. MazF-mediated cell death in Escherichia coli: a point of no return. J. Bacteriol. 186:8295-8300.[Abstract/Free Full Text]
    5. 5
  5. Anantharaman, V., and L. Aravind. 2003. New connections in the prokaryotic toxin-antitoxin network: relationship with the eukaryotic nonsense-mediated RNA decay system. Genome Biol. 4:R81.[CrossRef][Medline]
    6. 6
  6. Arcus, V. L., P. B. Rainey, and S. J. Turner. 2005. The PIN-domain toxin-antitoxin array in mycobacteria. Trends Microbiol. 13:360-365.[CrossRef][Medline]
    7. 7
  7. Bahassi, E. M., M. A. Salmon, L. Van Melderen, P. Bernard, and M. Couturier. 1995. F plasmid CcdB killer protein: ccdB gene mutants coding for non-cytotoxic proteins which retain their regulatory functions. Mol. Microbiol. 15:1031-1037.[Medline]
    8. 8
  8. Bernard, P., and M. Couturier. 1992. Cell killing by the F plasmid CcdB protein involves poisoning of DNA-topoisomerase II complexes. J. Mol. Biol. 226:735-745.[CrossRef][Medline]
    9. 9
  9. Bernard, P., K. E. Kezdy, L. Van Melderen, J. Steyaert, L. Wyns, M. L. Pato, P. N. Higgins, and M. Couturier. 1993. The F plasmid CcdB protein induces efficient ATP-dependent DNA cleavage by gyrase. J. Mol. Biol. 234:534-541.[CrossRef][Medline]
    10. 10
  10. Brosius, J., and A. Holy. 1984. Regulation of ribosomal RNA promoters with a synthetic lac operator. Proc. Natl. Acad. Sci. USA 81:6929-6933.[Abstract/Free Full Text]
    11. 11
  11. Buts, L., J. Lah, M. H. Dao-Thi, L. Wyns, and R. Loris. 2005. Toxin-antitoxin modules as bacterial metabolic stress managers. Trends Biochem. Sci. 30:672-679.[Medline]
    12. 12
  12. Chaveroche, M. K., J. M. Ghigo, and C. d'Enfert. 2000. A rapid method for efficient gene replacement in the filamentous fungus Aspergillus nidulans. Nucleic Acids Res. 28:E97.
    13. 13
  13. Cherepanov, P. P., and W. Wackernagel. 1995. Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. Gene 158:9-14.[CrossRef][Medline]
    14. 14
  14. Christensen, S. K., and K. Gerdes. 2004. Delayed-relaxed response explained by hyperactivation of RelE. Mol. Microbiol. 53:587-597.[CrossRef][Medline]
    15. 15
  15. Christensen, S. K., M. Mikkelsen, K. Pedersen, and K. Gerdes. 2001. RelE, a global inhibitor of translation, is activated during nutritional stress. Proc. Natl. Acad. Sci. USA 98:14328-14333.[Abstract/Free Full Text]
    16. 16
  16. Christensen, S. K., K. Pedersen, F. G. Hansen, and K. Gerdes. 2003. Toxin-antitoxin loci as stress-response-elements: ChpAK/MazF and ChpBK cleave translated RNAs and are counteracted by tmRNA. J. Mol. Biol. 332:809-819.[CrossRef][Medline]
    17. 17
  17. Christensen-Dalsgaard, M., and K. Gerdes. 2006. Two higBA loci in the Vibrio cholerae superintegron encode mRNA cleaving enzymes and can stabilize plasmids. Mol. Microbiol. 62:397-411.[CrossRef][Medline]
    18. 18
  18. Clément, J.-M., C. Wilde, S. Bachellier, P. Lambert, and M. Hofnung. 1999. IS1397 is active for transposition into the chromosome of Escherichia coli K-12 and inserts specifically into palindromic units of bacterial interspersed mosaic elements. J. Bacteriol. 181:6929-6936.[Abstract/Free Full Text]
    19. 18
  19. Cooper, T. F., and J. A. Heinemann. 2000. Postsegregational killing does not increase plasmid stability but acts to mediate the exclusion of competing plasmids. Proc. Natl. Acad. Sci. USA 97:12643-12648.[Abstract/Free Full Text]
    20. 19
  20. Couturier, M., E. M. Bahassi, and L. Van Melderen. 1998. Bacterial death by DNA gyrase poisoning. Trends Microbiol. 6:269-275.[CrossRef][Medline]
    21. 20
  21. Critchlow, S. E., M. H. O'Dea, A. J. Howells, M. Couturier, M. Gellert, and A. Maxwell. 1997. The interaction of the F plasmid killer protein, CcdB, with DNA gyrase: induction of DNA cleavage and blocking of transcription. J. Mol. Biol. 273:826-839.[CrossRef][Medline]
    22. 21
  22. Datsenko, K. A., and B. L. Wanner. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. USA 97:6640-6645.[Abstract/Free Full Text]
    23. 22
  23. Engelberg-Kulka, H., R. Hazan, and S. Amitai. 2005. mazEF: a chromosomal toxin-antitoxin module that triggers programmed cell death in bacteria. J. Cell Sci. 118:4327-4332.[Abstract/Free Full Text]
    24. 23
  24. Gerdes, K. 2000. Toxin-antitoxin modules may regulate synthesis of macromolecules during nutritional stress. J. Bacteriol. 182:561-572.[Free Full Text]
    25. 24
  25. Gerdes, K., S. K. Christensen, and A. Lobner-Olesen. 2005. Prokaryotic toxin-antitoxin stress response loci. Nat. Rev. Microbiol. 3:371-382.[CrossRef][Medline]
    26. 25
  26. Glansdorff, N. 1965. Topography of cotransducible arginine mutations in Escherichia coli K-12. Genetics 51:167-179.[Free Full Text]
    27. 26
  27. Gotfredsen, M., and K. Gerdes. 1998. The Escherichia coli relBE genes belong to a new toxin-antitoxin gene family. Mol. Microbiol. 29:1065-1076.[CrossRef][Medline]
    28. 27
  28. Gronlund, H., and K. Gerdes. 1999. Toxin-antitoxin systems homologous with relBE of Escherichia coli plasmid P307 are ubiquitous in prokaryotes. J. Mol. Biol. 285:1401-1415.[CrossRef][Medline]
    29. 28
  29. Guzman, L.-M., D. Belin, M. J. Carson, and J. Beckwith. 1995. Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J. Bacteriol. 177:4121-4130.[Abstract/Free Full Text]
    30. 29
  30. Hayes, F. 2003. Toxins-antitoxins: plasmid maintenance, programmed cell death, and cell cycle arrest. Science 301:1496-1499.[Abstract/Free Full Text]
    31. 30
  31. Hazan, R., B. Sat, and H. Engelberg-Kulka. 2004. Escherichia coli mazEF-mediated cell death is triggered by various stressful conditions. J. Bacteriol. 186:3663-3669.[Abstract/Free Full Text]
    32. 31
  32. Jaffé, A., T. Ogura, and S. Hiraga. 1985. Effects of the ccd function of the F plasmid on bacterial growth. J. Bacteriol. 163:841-849.[Abstract/Free Full Text]
    33. 32
  33. Kobayashi, I. 2001. Behavior of restriction-modification systems as selfish mobile elements and their impact on genome evolution. Nucleic Acids Res. 29:3742-3756.[Abstract/Free Full Text]
    34. 33
  34. Light, J., and S. Molin. 1982. The sites of action of the two copy number control functions of plasmid R1. Mol. Gen. Genet. 187:486-493.[CrossRef][Medline]
    35. 34
  35. Maki, S., S. Takiguchi, T. Miki, and T. Horiuchi. 1992. Modulation of DNA supercoiling activity of Escherichia coli DNA gyrase by F plasmid proteins. Antagonistic actions of LetA (CcdA) and LetD (CcdB) proteins. J. Biol. Chem. 267:12244-12251.[Abstract/Free Full Text]
    36. 35
  36. Masuda, Y., K. Miyakawa, Y. Nishimura, and E. Ohtsubo. 1993. chpA and chpB, Escherichia coli chromosomal homologs of the pem locus responsible for stable maintenance of plasmid R100. J. Bacteriol. 175:6850-6856.[Abstract/Free Full Text]
    37. 36
  37. Metzger, S., I. B. Dror, E. Aizenman, G. Schreiber, M. Toone, J. D. Friesen, M. Cashel, and G. Glaser. 1988. The nucleotide sequence and characterization of the relA gene of Escherichia coli. J. Biol. Chem. 263:15699-15704.[Abstract/Free Full Text]
    38. 37
  38. Miller, J. H. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
    39. 38
  39. Pandey, D. P., and K. Gerdes. 2005. Toxin-antitoxin loci are highly abundant in free-living but lost from host-associated prokaryotes. Nucleic Acids Res. 33:966-976.[Abstract/Free Full Text]
    40. 39
  40. Pedersen, K., S. K. Christensen, and K. Gerdes. 2002. Rapid induction and reversal of a bacteriostatic condition by controlled expression of toxins and antitoxins. Mol. Microbiol. 45:501-510.[CrossRef][Medline]
    41. 40
  41. Perna, N. T., J. D. Glasner, V. Burland, and G. Plunkett III. 2002. The genomes of Escherichia coli K-12 and pathogenic E. coli, p. 3-53. In M. S. Donnenberg, (ed.), Escherichia coli: virulence mechanisms of a versatile pathogen. Academic Press, San Diego, CA.
    42. 41
  42. Rowe-Magnus, D. A., A. M. Guerout, L. Biskri, P. Bouige, and D. Mazel. 2003. Comparative analysis of superintegrons: engineering extensive genetic diversity in the Vibrionaceae. Genome Res. 13:428-442.[Abstract/Free Full Text]
    43. 42
  43. Salmon, M. A., L. Van Melderen, P. Bernard, and M. Couturier. 1994. The antidote and autoregulatory functions of the F plasmid CcdA protein: a genetic and biochemical survey. Mol. Gen. Genet. 244:530-538.[CrossRef][Medline]
    44. 43
  44. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
    45. 44
  45. Santos-Sierra, S., R. Giraldo, and R. Diaz-Orejas. 1997. Functional interactions between homologous conditional killer systems of plasmid and chromosomal origin. FEMS Microbiol. Lett. 152:51-56.[CrossRef][Medline]
    46. 45
  46. Santos Sierra, S., R. Giraldo, and R. Diaz Orejas. 1998. Functional interactions between chpB and parD, two homologous conditional killer systems found in the Escherichia coli chromosome and in plasmid R1. FEMS Microbiol. Lett. 168:51-58.[CrossRef][Medline]
    47. 46
  47. Sat, B., R. Hazan, T. Fisher, H. Khaner, G. Glaser, and H. Engelberg-Kulka. 2001. Programmed cell death in Escherichia coli: some antibiotics can trigger mazEF lethality. J. Bacteriol. 183:2041-2045.[Abstract/Free Full Text]
    48. 47
  48. Sat, B., M. Reches, and H. Engelberg-Kulka. 2003. The Escherichia coli mazEF suicide module mediates thymineless death. J. Bacteriol. 185:1803-1807.[Abstract/Free Full Text]
    49. 48
  49. Talmadge, K., and W. Gilberg. 1980. Construction of plasmid vectors with unique PstI cloning sites in a signal sequence coding region. Gene 12:235-241.[CrossRef][Medline]
    50. 49
  50. Tam, J. E., and B. C. Kline. 1989. The F plasmid ccd autorepressor is a complex of CcdA and CcdB proteins. Mol. Gen. Genet. 219:26-32.[CrossRef][Medline]
    51. 50
  51. Tsuchimoto, S., Y. Nishimura, and E. Ohtsubo. 1992. The stable maintenance system pem of plasmid R100: degradation of PemI protein may allow PemK protein to inhibit cell growth. J. Bacteriol. 174:4205-4211.[Abstract/Free Full Text]
    52. 51
  52. Tsuchimoto, S., H. Ohtsubo, and E. Ohtsubo. 1988. Two genes, pemK and pemI, responsible for stable maintenance of resistance plasmid R100. J. Bacteriol. 170:1461-1466.[Abstract/Free Full Text]
    53. 52
  53. Van Melderen, L. 2002. Molecular interactions of the CcdB poison with its bacterial target, the DNA gyrase. Int. J. Med. Microbiol. 291:537-544.[CrossRef][Medline]
    54. 53
  54. Van Melderen, L., P. Bernard, and M. Couturier. 1994. Lon-dependent proteolysis of CcdA is the key control for activation of CcdB in plasmid-free segregant bacteria. Mol. Microbiol. 11:1151-1157.[CrossRef][Medline]
    55. 54
  55. Van Melderen, L., M. H. Thi, P. Lecchi, S. Gottesman, M. Couturier, and M. R. Maurizi. 1996. ATP-dependent degradation of CcdA by Lon protease. Effects of secondary structure and heterologous subunit interactions. J. Biol. Chem. 271:27730-27738.[Abstract/Free Full Text]
    56. 55
  56. Whittam, T. S., M. L. Wolfe, I. K. Wachsmuth, F. Ørskov, I. Ørskov, and R. A. Wilson. 1993. Clonal relationships among Escherichia coli strains that cause hemorrhagic colitis and infantile diarrhea. Infect. Immun. 61:1619-1629.[Abstract/Free Full Text]
    57. 56
  57. Wick, L. M., W. Qi, D. W. Lacher, and T. S. Whittam. 2005. Evolution of genomic content in the stepwise emergence of Escherichia coli O157:H7. J. Bacteriol. 187:1783-1791.[Abstract/Free Full Text]
    58. 57
  58. Zhou, Y., and S. Gottesman. 1998. Regulation of proteolysis of the stationary-phase sigma factor RpoS. J. Bacteriol. 180:1154-1158.[Abstract/Free Full Text]

Journal of Bacteriology, April 2007, p. 2712-2719, Vol. 189, No. 7
0021-9193/07/$08.00+0     doi:10.1128/JB.01679-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Mine, N., Guglielmini, J., Wilbaux, M., Van Melderen, L. (2009). The Decay of the Chromosomally Encoded ccdO157 Toxin-Antitoxin System in the Escherichia coli Species. Genetics 181: 1557-1566 [Abstract] [Full Text]  
  • Saavedra De Bast, M., Mine, N., Van Melderen, L. (2008). Chromosomal Toxin-Antitoxin Systems May Act as Antiaddiction Modules. J. Bacteriol. 190: 4603-4609 [Abstract] [Full Text]  
  • Tsilibaris, V., Maenhaut-Michel, G., Mine, N., Van Melderen, L. (2007). What Is the Benefit to Escherichia coli of Having Multiple Toxin-Antitoxin Systems in Its Genome?. J. Bacteriol. 189: 6101-6108 [Abstract] [Full Text]  
  • Magnuson, R. D. (2007). Hypothetical Functions of Toxin-Antitoxin Systems. J. Bacteriol. 189: 6089-6092 [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilbaux, M.
Right arrow Articles by Van Melderen, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilbaux, M.
Right arrow Articles by Van Melderen, L.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»